Tirzepatide is a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://sahilvnrx615736.bloggactivo.com/39652903/tirzepatide-a-new-frontier-in-diabetes-treatment